loading
Oramed Pharmaceuticals Inc stock is traded at $2.14, with a volume of 59,277. It is up +3.88% in the last 24 hours and up +0.47% over the past month. Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.
See More
Previous Close:
$2.06
Open:
$2.0805
24h Volume:
59,277
Relative Volume:
0.83
Market Cap:
$87.41M
Revenue:
$2.70M
Net Income/Loss:
$5.53M
P/E Ratio:
19.45
EPS:
0.11
Net Cash Flow:
$-10.55M
1W Performance:
+2.88%
1M Performance:
+0.47%
6M Performance:
-0.47%
1Y Performance:
-13.36%
1-Day Range:
Value
$2.0601
$2.15
1-Week Range:
Value
$2.045
$2.15
52-Week Range:
Value
$1.82
$3.09

Oramed Pharmaceuticals Inc Stock (ORMP) Company Profile

Name
Name
Oramed Pharmaceuticals Inc
Name
Phone
646-844-1164
Name
Address
1185 AVENUE OF THE AMERICAS, 3RD FLOOR, NEW YORK, NY
Name
Employee
13
Name
Twitter
@OramedPharma
Name
Next Earnings Date
2025-08-19
Name
Latest SEC Filings
Name
ORMP's Discussions on Twitter

Compare ORMP with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
ORMP
Oramed Pharmaceuticals Inc
2.14 84.96M 2.70M 5.53M -10.55M 0.11
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.12 99.96B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
589.48 60.83B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
454.38 59.89B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
660.00 40.47B 3.06B 1.28B 447.35M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
313.67 37.96B 3.81B -644.79M -669.77M -6.24

Oramed Pharmaceuticals Inc Stock (ORMP) Upgrades & Downgrades

Date Action Analyst Rating Change
Jan-12-23 Downgrade Canaccord Genuity Buy → Hold
Feb-18-22 Initiated Cantor Fitzgerald Overweight
Apr-20-21 Initiated Canaccord Genuity Buy
Feb-09-21 Initiated National Securities Buy
Dec-03-20 Initiated Alliance Global Partners Buy
Mar-11-20 Initiated Aegis Capital Buy
Sep-11-19 Initiated Ladenburg Thalmann Buy
Dec-11-17 Resumed B. Riley FBR, Inc. Buy
May-26-16 Reiterated FBR Capital Outperform
Dec-01-15 Reiterated H.C. Wainwright Buy
Nov-19-15 Initiated FBR Capital Outperform
Apr-13-15 Resumed MLV & Co Buy
Jan-30-14 Reiterated Aegis Capital Buy
Jan-08-14 Reiterated Aegis Capital Buy
Jan-08-14 Initiated MLV & Co Buy
Dec-03-13 Initiated Aegis Capital Buy
View All

Oramed Pharmaceuticals Inc Stock (ORMP) Latest News

pulisher
Aug 20, 2025

Options Data Show Bullish Bias in Oramed Pharmaceuticals Inc.2025 Stock Rankings & Low Drawdown Trading Techniques - classian.co.kr

Aug 20, 2025
pulisher
Aug 19, 2025

Historical volatility pattern of Oramed Pharmaceuticals Inc. visualizedPortfolio Risk Report & Weekly High Potential Stock Alerts - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Is Oramed Pharmaceuticals Inc. forming a reversal patternCEO Change & Stock Market Timing Techniques - Newser

Aug 19, 2025
pulisher
Aug 19, 2025

Backtesting results for Oramed Pharmaceuticals Inc. trading strategiesEarnings Risk Report & Consistent Growth Equity Picks - Newser

Aug 19, 2025
pulisher
Aug 18, 2025

Will Oramed Pharmaceuticals Inc. Sustain Its Chart BreakoutRisk Management & Long-Term Safe Investment Plans - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Can machine learning forecast Oramed Pharmaceuticals Inc. recoveryJuly 2025 Gainers & Pattern Based Trade Signal System - Newser

Aug 18, 2025
pulisher
Aug 18, 2025

Oramed Posts Q2 Earnings Beat Amid Cost Efficiency Gains, Market Reacts Positively in the Medium Term - AInvest

Aug 18, 2025
pulisher
Aug 18, 2025

How high can Oramed Pharmaceuticals Inc. stock price go in 2025Gap Up & Daily Growth Stock Tips - Newser

Aug 18, 2025
pulisher
Aug 17, 2025

Published on: 2025-08-17 16:36:43 - Newser

Aug 17, 2025
pulisher
Aug 17, 2025

Oramed Posts Earnings Beat Amid Mixed Pharmaceutical Sector Response; Momentum Favors Long-Term Holders - AInvest

Aug 17, 2025
pulisher
Aug 17, 2025

Applying big data sentiment scoring on Oramed Pharmaceuticals Inc.2025 Earnings Impact & High Accuracy Investment Signals - Newser

Aug 17, 2025
pulisher
Aug 16, 2025

Is Oramed Pharmaceuticals Inc. the Top Chart Pick This WeekMarket Volume Summary & Intraday High Probability Alerts - 선데이타임즈

Aug 16, 2025
pulisher
Aug 16, 2025

Oramed Pharmaceuticals Inc. Sees Spike in Bullish Option FlowWeekly Stock Report & Verified Momentum Stock Ideas - newsyoung.net

Aug 16, 2025
pulisher
Aug 16, 2025

Can Oramed Pharmaceuticals Inc. lead its sector in growthMarket Activity Report & Weekly Breakout Watchlists - sundaytimes.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Recovery Signals Appearing in Oramed Pharmaceuticals Inc. ChartsWeekly Gains Report & Fast Entry High Yield Tips - sundaytimes.kr

Aug 16, 2025
pulisher
Aug 16, 2025

Can volume confirm reversal in Oramed Pharmaceuticals Inc.Weekly Investment Summary & Accurate Buy Signal Alerts - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Risk vs reward if holding onto Oramed Pharmaceuticals Inc.Quarterly Profit Report & Expert Approved Momentum Ideas - Newser

Aug 16, 2025
pulisher
Aug 16, 2025

Can a trend reversal in Oramed Pharmaceuticals Inc. lead to recovery2025 Volatility Report & Safe Capital Preservation Plans - Newser

Aug 16, 2025
pulisher
Aug 15, 2025

Is now a turning point for Oramed Pharmaceuticals Inc.July 2025 Recap & Low Risk Growth Stock Ideas - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Detecting price anomalies in Oramed Pharmaceuticals Inc. with AIJuly 2025 Pullbacks & Entry Point Strategy Guides - Newser

Aug 15, 2025
pulisher
Aug 15, 2025

Oramed Pharmaceuticals Inc. Consolidation Zone May Signal Accumulation2025 Investor Takeaways & Stock Market Timing Techniques - newsimpact.co.kr

Aug 15, 2025
pulisher
Aug 15, 2025

Oramed: Q2 Earnings Snapshot - Norwalk Hour

Aug 15, 2025
pulisher
Aug 14, 2025

What candlestick patterns are forming on Oramed Pharmaceuticals Inc.July 2025 Closing Moves & High Return Stock Watch Alerts - Newser

Aug 14, 2025
pulisher
Aug 14, 2025

Oramed Pharmaceuticals: Navigating Earnings Volatility and Strategic Alliances in a High-Stakes Biotech Landscape - AInvest

Aug 14, 2025
pulisher
Aug 14, 2025

Oramed Pharmaceuticals Inc. Stages Intraday Comeback — Trend ChangeJuly 2025 Fed Impact & Safe Entry Zone Identification - beatles.ru

Aug 14, 2025
pulisher
Aug 14, 2025

Oramed Pharmaceuticals Inc. Stock Support and Resistance Levels You Should KnowQuarterly Profit Report & Fast Entry Momentum Trade Alerts - Newser

Aug 14, 2025
pulisher
Aug 13, 2025

Oramed Pharmaceuticals shares rise 1.82% premarket after reporting Q1 revenue of $2 million. - AInvest

Aug 13, 2025
pulisher
Aug 13, 2025

Scilex Holding Company Announces S-4 Effectiveness, Denali-Semnur Merger Proposal, and Oramed Pharmaceuticals Enters Option Agreement with Scilex - AInvest

Aug 13, 2025
pulisher
Aug 12, 2025

How to use Fibonacci retracement on Oramed Pharmaceuticals Inc.2025 Market Outlook & Smart Swing Trading Alerts - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

How high can Oramed Pharmaceuticals Inc. stock goFree Watchlist for Low Risk High Return - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

How Oramed Pharmaceuticals Inc. stock performs during market volatilityFree Daily Chart Pattern Stock Forecast - Newser

Aug 12, 2025
pulisher
Aug 11, 2025

Alpha Tau Secures FDA Approval for Breakthrough Brain Cancer Treatment Trial, Raises $36.9M - Stock Titan

Aug 11, 2025
pulisher
Aug 11, 2025

What to expect from Oramed Pharmaceuticals Inc. in the next 30 daysFree Stock Market Entry Timing Signals - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Can you recover from losses in Oramed Pharmaceuticals Inc.Free Short Term High Yield Stock Tips - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Published on: 2025-08-10 20:12:47 - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

Intraday pattern recognizer results for Oramed Pharmaceuticals Inc.Daily Exit and Entry Price Prediction - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Oramed Pharmaceuticals Inc expected to post a loss of 19 cents a shareEarnings Preview - TradingView

Aug 08, 2025

Oramed Pharmaceuticals Inc Stock (ORMP) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading
$24.65
price up icon 0.94%
$85.04
price down icon 1.72%
$26.20
price up icon 0.73%
$110.88
price up icon 0.10%
$131.88
price down icon 0.54%
biotechnology ONC
$313.67
price down icon 0.10%
Cap:     |  Volume (24h):